𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Model-Based Development of a PPARγ Agonist, Rivoglitazone, to Aid Dose Selection and Optimize Clinical Trial Designs

✍ Scribed by Rohatagi, Shashank; Carrothers, Timothy J.; Jin, JinYan; Jusko, William J.; Khariton, Tatiana; Walker, Joseph; Truitt, Kenneth; Salazar, Daniel E.


Book ID
120065596
Publisher
Sage Publications
Year
2008
Tongue
English
Weight
433 KB
Volume
48
Category
Article
ISSN
0091-2700

No coin nor oath required. For personal study only.